News Briefs Valeant Pharmaceuticals inks $250 mln deal to acquire PE-backed Solta Medical brad meikle - 16 December 2013 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in